Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd-R Burmester

Showing results (81-90 of 293) with videos related to

Pageof 30
Sort By:
The Journal of Rheumatology|April 15, 2024
Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT)Gerd R Burmester, Filip Van den Bosch, John Tesser, et al.
The Journal of Rheumatology|October 11, 2002
Circulating proteasomes are markers of cell damage and immunologic activity in autoimmune diseasesKarl Egerer, Ulrike Kuckelkorn, Paul E Rudolph, et al.
RMD Open|April 19, 2019
Re-treatment with abatacept plus methotrexate for disease flare after complete treatment withdrawal in patients with early rheumatoid arthritis: 2-year results from the AVERT studyPaul Emery, Gerd R Burmester, Vivian P Bykerk, et al.
Annals of the Rheumatic Diseases|October 30, 2015
Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trialGerd R Burmester, William F Rigby, Ronald F van Vollenhoven, et al.
Arthritis and Rheumatism|September 5, 2002
Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndromeArne Hansen, Marcus Odendahl, Karin Reiter, et al.
Rheumatology International|October 21, 2018
On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritisVivian P Bykerk, Gerd R Burmester, Bernard G Combe, et al.
Annals of the Rheumatic Diseases|April 9, 2017
Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trialGerd R Burmester, William F Rigby, Ronald F van Vollenhoven, et al.
Annals of the Rheumatic Diseases|February 11, 2017
Carbamylation of vimentin is inducible by smoking and represents an independent autoantigen in rheumatoid arthritisCaroline Ospelt, Holger Bang, Eugen Feist, et al.
Arthritis Research & Therapy|March 18, 2006
Decrease in expression of bone morphogenetic proteins 4 and 5 in synovial tissue of patients with osteoarthritis and rheumatoid arthritisCarsten P Bramlage, Thomas Häupl, Christian Kaps, et al.
Arthritis Research & Therapy|November 14, 2009
Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trialVibeke Strand, Philip Mease, Gerd R Burmester, et al.
Pageof 30

Showing results (81-90 of 293) with videos related to

Sort By:
Pageof 30
The Journal of Rheumatology|April 15, 2024
Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT)Gerd R Burmester, Filip Van den Bosch, John Tesser, et al.
The Journal of Rheumatology|October 11, 2002
Circulating proteasomes are markers of cell damage and immunologic activity in autoimmune diseasesKarl Egerer, Ulrike Kuckelkorn, Paul E Rudolph, et al.
RMD Open|April 19, 2019
Re-treatment with abatacept plus methotrexate for disease flare after complete treatment withdrawal in patients with early rheumatoid arthritis: 2-year results from the AVERT studyPaul Emery, Gerd R Burmester, Vivian P Bykerk, et al.
Annals of the Rheumatic Diseases|October 30, 2015
Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trialGerd R Burmester, William F Rigby, Ronald F van Vollenhoven, et al.
Arthritis and Rheumatism|September 5, 2002
Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndromeArne Hansen, Marcus Odendahl, Karin Reiter, et al.
Rheumatology International|October 21, 2018
On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritisVivian P Bykerk, Gerd R Burmester, Bernard G Combe, et al.
Annals of the Rheumatic Diseases|April 9, 2017
Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trialGerd R Burmester, William F Rigby, Ronald F van Vollenhoven, et al.
Annals of the Rheumatic Diseases|February 11, 2017
Carbamylation of vimentin is inducible by smoking and represents an independent autoantigen in rheumatoid arthritisCaroline Ospelt, Holger Bang, Eugen Feist, et al.
Arthritis Research & Therapy|March 18, 2006
Decrease in expression of bone morphogenetic proteins 4 and 5 in synovial tissue of patients with osteoarthritis and rheumatoid arthritisCarsten P Bramlage, Thomas Häupl, Christian Kaps, et al.
Arthritis Research & Therapy|November 14, 2009
Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trialVibeke Strand, Philip Mease, Gerd R Burmester, et al.
Pageof 30